Assembly Biosciences, Inc. (ASMB)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $20.57
- As of
Kresmion compiles this page from ASMB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ASSEMBLY BIOSCIENCES, INC. (ASMB): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-13.
See the full ASMB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ASMB on one page. Preview it with sample data, then open it live with a free account.
Preview the ASMB dossierActive events for ASMB
- high13F: funds added
3 tracked funds increased ASMB this 2026Q2, institutional consensus
- mediumEarnings above estimates
Q2-2026: Beat consensus by 69.7%, EPS $-0.20 vs $-0.6596 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +265% to ASMB (2026Q2)
- high13F: large increase
RENAISSANCE TECHNOLOGIES LLC added +152% to ASMB (2026Q2)
- high13F: funds added
3 tracked funds increased ASMB this 2026Q1 - institutional consensus
FREE, NO ACCOUNT
Every event on ASMB, as it fires
You are seeing 5 of 12 events recorded on ASMB since 2026-05-30.
The five above landed across 4 days. The other 7 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ASMB (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 045396207 · 2026Q2 | $12.7M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 045396207 · 2026Q2 | $8.2M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 045396207 · 2026Q2 | $2.6M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 045396207 · 2026Q2 | $1.1M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 045396207 · 2026Q2 | $491K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ASMB
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
ASMB against its peers
ASMB's operating margin of -16.8% ranks in the 88th percentile of 11 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | ASMB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 72.3M USD | 9.7M USD | 75 | 13 |
| Operating margin | -16.8% | -394.9% | 88 | 11 |
| Net margin | -8.5% | -381.4% | 96 | 11 |
| Return on equity | -3.0% | -65.8% | 97 | 18 |
Peers (20): AUTL, NAUT, SPRY, ALT, TECX, ALLO, PRTA, OVID, INDP, CYDY, CCCC, AVTX, RZLT, RGNX, EDIT, MPLT, EPRX, FENC, YDES, RLMD. Left out: TRXB (no annual filing), EIKN (no annual filing), SCTX (no annual filing), AGMB (no annual filing), PRTCY (period gap). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (ASMB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow ASMB on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to ASMB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.